Preclinical safety study of a recombinant Streptococcus pyogenes vaccine formulated with aluminum adjuvant
Sign Up to like & getrecommendations! Published in 2017 at "Journal of Applied Toxicology"
DOI: 10.1002/jat.3349
Abstract: A recombinant vaccine composed of a fusion protein formulated with aluminum hydroxide adjuvant is under development for protection against diseases caused by Streptococcus pyogenes. The safety and local reactogenicity of the vaccine was assessed by… read more here.
Keywords: streptococcus pyogenes; formulated aluminum; safety; mice ... See more keywords